Osteosclerosis Autosomal Dominant Overview
Learn About Osteosclerosis Autosomal Dominant
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Medical Diagnostic Associates Inc
Michael Econs is an Endocrinologist in Indianapolis, Indiana. Dr. Econs is rated as an Elite provider by MediFind in the treatment of Osteosclerosis Autosomal Dominant. His top areas of expertise are Osteosclerosis Autosomal Dominant, Osteopetrosis, X-Linked Hypophosphatemia, and Hypophosphatemia.
Anna Teti practices in L'aquila, Italy. Ms. Teti is rated as an Elite expert by MediFind in the treatment of Osteosclerosis Autosomal Dominant. Her top areas of expertise are Osteosclerosis Autosomal Dominant, Osteopetrosis, Osteoporosis, Diastrophic Dysplasia, and Oophorectomy.
Michael Whyte is an Endocrinologist in Saint Louis, Missouri. Dr. Whyte is rated as an Elite provider by MediFind in the treatment of Osteosclerosis Autosomal Dominant. His top areas of expertise are Hypophosphatasia (HPP), Juvenile Paget's Disease, Rickets, Hypophosphatemia, and Leg or Foot Amputation. Dr. Whyte is currently accepting new patients.
Summary: The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched unrelated donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders that are amenable to treatment with hematopoietic stem cell transplant (HSCT). ...
Summary: This single-institution, phase II study is designed to test the ability to achieve donor hematopoietic engraftment while maintaining low rates of transplant-related mortality (TRM) using busulfan- and fludarabine-based conditioning regimens with busulfan therapeutic drug monitoring (TDM) for patients with various inherited metabolic disorders (IMD) and severe osteopetrosis (OP).